Didier Payen De La Garanderie

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Assistance Publique-Hopitaux De Paris. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Didier Payen De La Garanderie. Retrieved from https://idiyas.com/inventor/didier-payen-de-la-garanderie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 3 (Patent Applications = 3)

% Patents Active = 33.3

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

3 out of 331

Assistance Publique-Hopitaux De Paris

patents

Years Active: 2012-2018

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9943240 - Non-invasive method for measuring tissue perfusion state (2018-04-17),

2. 9416392 - Diagnosis of bacterial meningitis based on the measure of ROS production in a sample of cerebrospinal fluid (2016-08-16),

3. 8283131 - Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock (2012-10-09),

Title: The Innovations of Didier Payen De La Garanderie

Introduction

Didier Payen De La Garanderie is a notable inventor based in Paris, France. He has made significant contributions to the field of medical diagnostics, holding a total of 3 patents. His work focuses on non-invasive methods for assessing health conditions, showcasing his commitment to advancing medical technology.

Latest Patents

One of his latest patents is a non-invasive method for measuring tissue perfusion state. This innovative technique involves determining the tissue perfusion state in a patient by measuring variations in skin CO pressure and the perfusion index during a localized hyperthermia test. Another significant patent pertains to the diagnosis of bacterial meningitis. This method allows for in vitro diagnosis of bacterial infections in biological fluids, such as cerebrospinal fluid, by measuring the production of reactive oxygen species (ROS). A high level of ROS production indicates the presence of activated polymorphonuclear neutrophils, which is a hallmark of bacterial infection.

Career Highlights

Didier is associated with Assistance Publique-Hopitaux De Paris, where he applies his expertise in medical research and innovation. His work has been instrumental in developing new diagnostic methods that enhance patient care and treatment outcomes.

Collaborations

He collaborates with esteemed colleagues, including Anne-Claire Lukaszewicz and Fabrice Vallee, contributing to a dynamic research environment that fosters innovation.

Conclusion

Didier Payen De La Garanderie's contributions to medical diagnostics through his patents reflect his dedication to improving healthcare. His innovative approaches continue to pave the way for advancements in non-invasive medical technologies.

Profile summary based on public USPTO records.